Milestone Pharmaceuticals (MIST) Reports Q1 Loss, Lags Revenue Estimates
13/5 14:20
Milestone Pharmaceuticals (MIST) delivered earnings and revenue surprises of -433.33% and -99.68%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?...